Home / Discover / Fund

ICICI Prudential Nifty Pharma Index Fund

ICICI Prudential Mutual Fund Index fund Passive As of 2026-07-31
Compare Run analysis Research Academy
Holdings
22
Concentrated
Top 10 weight
79%
Concentration
Strategy
Index
Passive exposure
Equity
100%
Asset allocation

Portfolio

1Sectors 7Large positions 100.0%Top: Pharmaceuticals & Biotechnology 0.0%Cash

Market-cap allocation

Large cap55%
Mid cap37%
Small cap8%

Asset allocation

Equity100%

Top holdings

Sun Pharmaceutical Industries Ltd.EQUITY
21.3%
Divi's Laboratories Ltd.EQUITY
10.4%
Cipla Ltd.EQUITY
8.4%
Torrent Pharmaceuticals Ltd.EQUITY
7.6%
Laurus Labs Ltd.EQUITY
7.2%
Dr. Reddy's Laboratories Ltd.EQUITY
7.1%
Lupin Ltd.EQUITY
5.9%
Aurobindo Pharma Ltd.EQUITY
4.4%
Alkem Laboratories Ltd.EQUITY
3.4%
Glenmark Pharmaceuticals Ltd.EQUITY
3.4%

AI Smart summary

Portfolio read

  • 100% equity.
  • Passive index strategy; portfolio differences should primarily reflect index tracking and cash management.
  • Largest equity sector is Pharmaceuticals & Biotechnology at 100.0% of the portfolio.

Watchpoints

  • Compact 22-position portfolio; each large position can materially affect returns.
  • Top 10 positions account for 79%, indicating high portfolio concentration.
  • Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 100%.

Auto-generated from fund metrics. Educational only - not investment advice.

Peer comparison

Similar index portfolios by equity allocation and concentration.

Nippon India Nifty Pharma ETF22 holdings · 79% top 10
Kotak Nifty Chemicals ETF21 holdings · 78% top 10
IB59-Groww Nifty Chemicals ETF21 holdings · 78% top 10
Axis NIFTY Healthcare ETF22 holdings · 78% top 10
HDFC Nifty50 Value 20 ETF22 holdings · 78% top 10
Aditya Birla Sun Life NIFTY Healthcare ETF22 holdings · 78% top 10

Sector exposure

Full industry / sector breakdown aggregated from the fund's holdings.

Pharmaceuticals & Biotechnology100.0%